Home  > Clinical services  >  BRCA Gene Testing For Ovarian Cancer  > Intended group

1. All patients who are suffered from ovarian cancer (especially for high-level serous ovarian cancer patients);

2. Healthy family members of ovarian tumor patients, whose BRCA1 / 2 genetic detection results are positive;

3. High-level serous ovarian cancer patients, who are sensitive to platinum-based drugs and had received ≥2 kinds of platinum-containing regimens.


All rights reserved Annoroad Gene Technology 京ICP备12029022号-1